Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
2.78
-0.14 (-4.79%)
At close: Jun 05, 2025, 3:59 PM
2.77
-0.36%
Pre-market: Jun 06, 2025, 04:45 AM EDT
-4.79% (1D)
| Bid | 2.65 |
| Market Cap | 299.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -258.03M |
| EPS (ttm) | -2.63 |
| PE Ratio (ttm) | -1.06 |
| Forward PE | -1.74 |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 4,338,963 |
| Avg. Volume (20D) | 4,497,501 |
| Open | 2.96 |
| Previous Close | 2.92 |
| Day's Range | 2.73 - 2.96 |
| 52-Week Range | 2.19 - 26.98 |
| Beta | 0.68 |
About RCKT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-62.84%
Rocket Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
3 weeks ago
+11.06%
Rocket Pharmaceuticals shares are trading higher after the company presented preliminary data from its Phase 1 trial of RP-A601.
22 hours ago · accessnewswire.com
Levi & Korsinsky Investigates Rocket Pharmaceuticals, Inc. (RCKT) Over Possible Securities FraudNEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT...
